Dr. Shruti K. Gohil, a board-certified UCI Health specialist in infectious diseases, is the associate medical director for UCI Health Epidemiology and Infection Prevention. Her clinical interests include hospital epidemiology, infection prevention, communicable disease transmission and multidrug resistant organism infections.
She led the UCI Health response to the novel coronavirus pandemic, including the clinical and epidemiologic assessment of healthcare providers and patients, COVID-19 testing and vaccination, exposure definition and response, contact tracing, vaccination and infection prevention strategies to limit viral spread.
Gohil earned her medical degree and a master's in public health from Tufts University School of Medicine in Boston, Mass. She completed an internal medicine residency at the UC Davis School of Medicine, followed by a clinical and research fellowship in infectious diseases at the Albert Einstein School of Medicine in New York City.
Her research focus is to understand what places individuals and populations at risk for infectious diseases and how to mitigate that risk as quickly as possible. This includes devising innovative ways to evaluate, detect and intervene in the spread of healthcare-associated infections. She developing a novel scoring system that standardized how central lines are assessed, changing clinical responses and dramatically reducing infection risk at participating hospitals, clinical facilities and nursing homes. She also led statewide population studies to help reduce the risk associated with infection-related hospital readmissions and sepsis.
Gohil is currently the lead investigator of four national clinical trials to determine patient risk for multidrug-resistant bacterial infections and create real-time physician prompts to limit the use of extended-spectrum antibacterial drugs. If successful, these trials will help improve antibiotic use in hospitalized patients.